
HAdV-1 Hexon protein 229-242, LMYYNSTGNMGVLAG
Description
About HAdV-1 Hexon protein 229-242, LMYYNSTGNMGVLAG
The Human Adenovirus (HAdV) C serotype 1 (HAdV-1) Hexon protein Peptide (IEDB: 138201) is a high quality epitope peptide for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxicity or proliferation assays. The Hexon protein Peptide, H-LMYYNSTGNMGVLAG-OH (Uniprot: Q04965 aa: 229-242) from JPT is produced under strict quality control and quality management.
HAdV-1 Hexon protein 229-242, LMYYNSTGNMGVLAG - Specifications
- Peptide sequence: H-LMYYNSTGNMGVLAG-OH
- Amount: 10 mg (10 x 1 mg)
- Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS)
- Counterion: TFA
- Delivery Format: Freeze-dried in glass vial
- Application(s): T-cell Immunity
- Condition(s)/Topic(s): Infection
- Standard Delivery Time: approx. 3 weeks
JPT’s Antigen Peptides
Find your antigen peptide and select the connected PepMix™ Peptide Pool for efficient immune monitoring, mapping of T cell epitopes or development of immunotherapy and vaccines. JPT Peptide Technologies has substantial, long-standing expertise in providing peptides, peptidomimetics, and proteins to the global scientific community. Our highly skilled and committed scientific staff ensures that the most appropriate methods and techniques are selected for every synthesis project. All our catalog peptides are provided with HPLC-MS analyses to confirm the identity and demonstrate the high quality of our peptides.
Not found what you are looking for? Take a look at our Custom Peptide Synthesis!
Benefits of JPT’s Antigen Peptides
- All peptides are made in Germany
- Bulk orders or custom peptide snythesis upon request
- Synthesis protocols designed to avoid toxic contaminants and side products
- Provision of freeze dried aliquots for enhanced stability
- Proven track record for applications in clinical studies
- Order the connected PepMix™ Peptide Pool with your peptide!
References
References for HAdV-1 Hexon protein 229-242, LMYYNSTGNMGVLAG
References:
Read References with JPT’s Antigen Peptides
HAdV-1 Hexon protein 229-242, LMYYNSTGNMGVLAG has been described in:
Ex vivo detection of adenovirus specific CD4+ T-cell responses to HLA-DR-epitopes of the Hexon protein show a contracted specificity of T(HELPER) cells following stem cell transplantation., Virology, 2010 (PMID: 19962170)
Virus-specific T cells for adenovirus infection after stem cell transplantation are highly effective and class II HLA restricted., Blood Adv, 2021 (PMID: 34473237)
Optimized Anchor-Modified Peptides Targeting Mutated RAS Are Promising Candidates for Immunotherapy., Front Immunol, 2022 (PMID: 35720289)
Documentation
Documentation for HAdV-1 Hexon protein 229-242, LMYYNSTGNMGVLAG
Properties
Properties of HAdV-1 Hexon protein 229-242, LMYYNSTGNMGVLAG
Properties | Values |
---|---|
Application: | T-cell immunity |
Category: | Antigen Peptides |
Condition / Topic: | Infection |
Layout: | Freeze-dried in glass vial |
Organism: | Human Adenovirus (HAdV) |
Protein Name: | Hexon protein |
Purity: | Trial Grade: each peptide purified to > 90% (HPLC/MS) |
Quantification: | No, Yes |
Further Information to HAdV-1 Hexon protein 229-242, LMYYNSTGNMGVLAG
Information | Values |
---|---|
Sequence: | H-LMYYNSTGNMGVLAG-OH |
Specifications: | 15mer peptide as TFA salt |